Indefinite Delivery Contract SPE2DX15D9888

The federal contract IDV award described is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Illinois. The contract, valued at up to $499,999,999, runs through December 31, 2025 and allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

The IDC covers a vast array of pharmaceutical products, from common medications to specialized drugs and medical supplies, including flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptives, oncology drugs, and specialty medications. These products are primarily delivered to the DLA's Medical Supply Chain division, which then distributes them to various Department of Defense (DoD) healthcare facilities globally. The contract complements DMS Pharmaceutical Group's separate prime vendor contracts for direct distribution of prescription drugs and pharmacy services to DoD sites, solidifying the company's position as a crucial supplier in the federal pharmaceutical supply chain.